These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14088160)

  • 1. [BLOOD LIPOPROTEIN LIPASE AND ITS PROPERTIES AS A COMPONENT OF THE PHYSIOLOGICAL ANTICOAGULANT SYSTEM].
    KUDRIASHOV BA; BAZAZIAN GG; BONFITTO LL
    Vopr Med Khim; 1963; 9():533-5. PubMed ID: 14088160
    [No Abstract]   [Full Text] [Related]  

  • 2. [LIPOPROTEIN LIPASE AS A HUMORAL AGENT OF THE PHYSIOLOGICAL ANTICOAGULATING SYSTEM].
    KUDRIASHOV BA; BAZAZIAN GG; TRAPEZNIKOVA SS; NOSOVA VN
    Biull Eksp Biol Med; 1963 May; 55():20-5. PubMed ID: 14077737
    [No Abstract]   [Full Text] [Related]  

  • 3. SUBLINGUAL HEPARIN; THE INABILITY TO DETECT LIPID-CLEARING OR ANTICOAGULANT EFFECTS OF HIGH DOSES.
    SPUDIS EV; HUTAFF LW; MILLER HS; LOFLAND H
    Neurology; 1965 May; 15():486-90. PubMed ID: 14288641
    [No Abstract]   [Full Text] [Related]  

  • 4. THE EFFECT OF PROLONGED TREATMENT WITH HEPARIN ON LIPOPROTEIN-LIPASE ACTIVITY IN THE BLOOD.
    BOBERG J
    J Atheroscler Res; 1965; 5(3):340-2. PubMed ID: 14290297
    [No Abstract]   [Full Text] [Related]  

  • 5. [COMPARISON OF SOME EFFECTS OF HEPARIN AND THE PERORAL HEPARINOID "ATEROID" IN RATS].
    CEPELIK J; CERNOHORSKY M
    Cas Lek Cesk; 1963 Nov; 102():1291-4. PubMed ID: 14111755
    [No Abstract]   [Full Text] [Related]  

  • 6. [Research on lipoprotein lipase. III. Post-heparin lipoprotein lipase in man under normal and pathological conditions].
    SANDHOFER F; SAILER S; BRAUNSTEINER H
    Klin Wochenschr; 1961 Sep; 39():968-71. PubMed ID: 14496851
    [No Abstract]   [Full Text] [Related]  

  • 7. SERUM REQUIREMENT FOR RELEASE OF HEPARIN-INDUCED LIPASE FROM PERFUSED RAT HEART.
    CRASS MF; MENG HC
    Am J Physiol; 1964 Mar; 206():610-4. PubMed ID: 14162310
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative lipoprotein lipase activating and anticoagulant effects of heparin and heparitin monosulfates.
    GROSSMAN BJ; CIFONELLI JA
    J Lab Clin Med; 1962 Jun; 59():1020-5. PubMed ID: 13902291
    [No Abstract]   [Full Text] [Related]  

  • 9. EFFECT OF HEPARIN ON DISAPPEARANCE OF THE CHOLESTEROL MOIETY OF AN INJECTED CHOLESTEROL-C14-LABELED, VERY LOW-DENSITY CHYLE LIPOPROTEIN FRACTION FROM THE CIRCULATION OF THE RAT.
    LOSSOW WJ; NAIDOO SS; CHAIKOFF IL
    J Lipid Res; 1963 Oct; 4():419-23. PubMed ID: 14168185
    [No Abstract]   [Full Text] [Related]  

  • 10. [Heparin and lipoprotein lipase].
    MOSSO HE; PERGOLA F
    Dia Med; 1962 Mar; 34():220-2. PubMed ID: 14476563
    [No Abstract]   [Full Text] [Related]  

  • 11. LIPOLYTIC ACTIVITY IN THE BLOOD AFTER LIPASE INGESTION.
    TIDWELL HC; MCPHERSON JC; MOORE WT; POPE JL; FREEMAN A
    Proc Soc Exp Biol Med; 1964 Jul; 116():720-3. PubMed ID: 14194643
    [No Abstract]   [Full Text] [Related]  

  • 12. [On influencing the physiological coagulation time and the clearing factor by total body inunction with alpha-heparin and heparinoid ointments].
    STUETTGEN G; BRUESTER H
    Dermatol Wochenschr; 1960 Jan; 141():97-102. PubMed ID: 13835417
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma lipoprotein lipase after subcutaneous heparin.
    CONNOR WE; ARMSTRONG ML
    Circulation; 1961 Jul; 24():87-93. PubMed ID: 13695086
    [No Abstract]   [Full Text] [Related]  

  • 14. HEPARIN AND THE ELECTROPHORETIC MOBILITY OF BETA-LIPOPROTEIN IN CORONARY DISEASE.
    GROVER ME
    Am J Cardiol; 1965 Jan; 15():13-6. PubMed ID: 14248273
    [No Abstract]   [Full Text] [Related]  

  • 15. DETERMINATION OF HEPARIN-INDUCED LIPOPROTEIN LIPASE ACTIVITY IN HUMAN PLASMA.
    BOBERG J; CARLSON LA
    Clin Chim Acta; 1964 Nov; 10():420-7. PubMed ID: 14230938
    [No Abstract]   [Full Text] [Related]  

  • 16. AN INVESTIGATION OF ROUTES OF ADMINISTRATION OF HEPARIN OTHER THAN INJECTION.
    WINDSOR E; FREEMAN L
    Am J Med; 1964 Sep; 37():408-16. PubMed ID: 14209287
    [No Abstract]   [Full Text] [Related]  

  • 17. [ANTICOAGULANT DRUG THERAPY IN MYOCARDIAL INFARCT].
    MATSUOKA S; HOMMA T
    Sogo Rinsho; 1964 Mar; 13():463-71. PubMed ID: 14140834
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of heparin and a semi-synthetic heparin analogue on platelet aggregation, lipoprotein lipase and other laboratory tests in surgical patients.
    Törngren S; Norén I; Forsskåhl B; Sipilä H
    Thromb Res; 1983 Jun; 30(5):527-34. PubMed ID: 6412390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of various vascular regions in the liberation of the clearing factor after injection of heparin].
    LEMARCHAND H; PARAMELLE B
    J Physiol (Paris); 1961; 53():408-9. PubMed ID: 13760715
    [No Abstract]   [Full Text] [Related]  

  • 20. HEPARIN LEVELS DURING AND AFTER HYPOTHERMIC PERFUSION.
    WRIGHT JS; OSBORN JJ; PERKINS HA; GERBODE F
    J Cardiovasc Surg (Torino); 1964; 5():244-50. PubMed ID: 14166697
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.